Press Releases
Press Releases
More Press Releases
View Older Stories View Newer Stories-
The Daniels Corporation Unveils 2023 Impact Report, Highlighting Social Impact Initiatives and Progress on the Decarbonization Roadmap
-
UFC and Aires Tech Announce Multi-Year Global Marketing Partnership
-
Cabral Gold Drills 11m @ 33.0 g/t gold at the Machichie NE Target, Cuiú Cuiú Gold District, Brazil
-
Mako Mining Reissues Two Exploration Press Releases With the Same Technical Information Reviewed by a Different Qualified Person
-
First Majestic Releases 2023 Annual Report
-
Theralase(R) Release's 1Q2024 Financial Statements
-
Cathedra Bitcoin Announces First Quarter 2024 Financial Results
-
Elevate Festival Returns to Toronto October 1-3, Doubling Down on Startup Founders, Women in Tech, New Content Tracks and More
-
ASTA-USA Translation Services, Inc. Warns Businesses About Relying on AI Tools for Professional Translation Work
-
Ynvisible Announces Investor Webinar and Grants Stock Options
-
Ionik Announces Continued Growth in First Quarter 2024
-
Durham Black Inc. Appoints New President, COO and Expands Board of Directors
-
Incident IQ Partners with Level Access to Enhance Digital Accessibility
-
Aya Gold & Silver Announces Release of Fourth Sustainability Report
-
LSL Pharma Group Reports Record Revenues and Margins for the First Quarter 2024
-
Notification on transactions concluded by a person associated to a management body of Grigeo Group AB
-
Elevar Therapeutics Reports Landmark Median Overall Survival of 23.8 Months in First-Line Treatment for Unresectable Hepatocellular Carcinoma
-
Omega Therapeutics To Participate In Two Upcoming Investor Conferences
-
Troilus Discovers New At-Surface Gold Zone ‘West Rim’ With Intercept of 1.37 g/t AuEq Over 11m Within 200m of Reserve Pit and Confirms Continuity of Zone X22 Mineralization to Depth of 550m
-
BiomX to Present Phase 1b/2a Clinical Trial Data for BX004 at the 47th European Cystic Fibrosis Conference and at ASM Microbe 2024
-
Harfang Announces Summer Exploration Plans at Its Gold and CSM Properties in Eeyou Istchee James Bay, Quebec
-
17 Education & Technology Group Inc. to Report First Quarter 2024 Unaudited Financial Results on June 5, 2024
-
Compugen to Receive Milestone Payment Triggered by Dosing of First Patient in the Second Phase 3 Trial Evaluating Rilvegostomig
-
PreludeDx Presents New Data Highlighting Ability of DCISionRT® to Predict Benefit of Radiation Therapy in DCIS Patients, Independent of Endocrine Therapy (ET)
-
WILLOW ANNOUNCES MULTI-PRODUCT DEVELOPMENT AND LICENSING PARTNERSHIP WITH LAURUS LABS FOR MANUFACTURING ACTIVE PHARMACEUTICAL INGREDIENTS
-
Reservoir Media Announces Fourth Quarter and Fiscal Year 2024 Results
-
Main Street Announces New Portfolio Investment
-
Lantronix to Showcase AI-Driven Out-Of-Band Management Solutions at Cisco Live
-
Tencarva Machinery Company, Backed by Bessemer Investors, Acquires Tri-State Coating & Machine
-
Servier Initiates Critical Dialogue on AYA Cancer Survivorship at ASCO 2024
-
BioLineRx Announces Clinical Trial Agreement with St. Jude Children's Research Hospital, Inc. to Evaluate Motixafortide for CD34+ Hematopoietic Stem Cell (HSC) Mobilization For Gene Therapy Applicatio
-
PMV Pharmaceuticals to Participate at Upcoming Investor Conferences in June
-
KELIA Expands Its Offerings and Introduces Non-Carbonated Hemp Beverages
-
Siyata Mobile Granted New US Patent for Innovative Push-to-Talk Vehicle Kit
-
Consumer and Industry Advocates Outline Reforms to Property Tax Foreclosure Laws to Promote Sustainable Homeownership
-
Kain Capital Hires Solomon Eskinazi as General Counsel
-
Lufax Announces Results of Annual General Meeting
-
Canopy Growth Reports Fourth Quarter and Fiscal Year 2024 Financial Results; Q4 FY2024 Net Revenue increased 7% year-over-year, or 16% excluding divested businesses
-
Cheche Group Reports First Quarter 2024 Unaudited Financial Results
-
Zentalis Pharmaceuticals to Present at the Jefferies Global Healthcare Conference
-
Chimerix to Participate in Fireside Chat at Jefferies Global Healthcare Conference
-
Preqin announces launch of Term Intelligence
-
Elastin Biosciences to Participate in 2024 BIO International Convention in San Diego
-
Celcuity Inc. Announces Plan to Initiate a Phase 3 Clinical Trial for Gedatolisib as First-Line Treatment for HR+/HER2- Advanced Breast Cancer and Secures Approximately $62 Million Debt Financing
-
LUCA REPORTS STRONG Q1 2024 WITH C$7.3M OF NET INCOME
-
Black Market Gambling Steals $9.5 Billion From NY, NJ, MN
-
SpartanNash Announces First Quarter Fiscal 2024 Results
-
BetDEX Disrupts Sports Betting Industry with Exchange built for Smart Bettors
-
Capital Square and Greystar's The Otis Earns 2024 CoStar Impact Award for Multifamily Development of the Year
-
New Research Shows Substantial Impact on Participants in Compassion Programs


